Early research (Phase 1)Study completedNCT00768404What this trial is testingEvaluate the Pharmacokinetics of VI-0521 Subjects With Renal ImpairmentWho this might be right forRenal Impairment VIVUS LLC 32
Large-scale testing (Phase 3)Looking for participantsNCT06217302What this trial is testingSotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney DiseaseWho this might be right forDiabetic NephropathiesKidney Failure, ChronicDiabetes Mellitus Type 1+1 more Alessandro Doria 150
Large-scale testing (Phase 3)Study completedNCT00500682What this trial is testingAST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)Who this might be right forChronic Kidney Disease Tanabe Pharma Corporation 1,020
Early research (Phase 1)Study completedNCT05491642What this trial is testingA Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple DosesWho this might be right forChronic Kidney DiseaseHypertension Bayer 56
Testing effectiveness (Phase 2)WithdrawnNCT04531579What this trial is testingValproic Acid (VPA) for Acute Kidney Injury (AKI) in Trauma PatientsWho this might be right forAcute Kidney InjuryIschemia Reperfusion Injury Westat
Post-approval studies (Phase 4)Study completedNCT01981941What this trial is testingPost-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal ImpairmentWho this might be right forRestless Legs Syndrome (RLS) Astellas Pharma Inc 19
Early research (Phase 1)Study completedNCT05718648What this trial is testingTest How BI 1015550 is Taken up in the Blood of People With and Without Kidney ProblemsWho this might be right forRenal InsufficiencyHealthy Boehringer Ingelheim 26
Large-scale testing (Phase 3)Looking for participantsNCT07374042What this trial is testingKetoanalogue Supplementation for Muscle Protection in CKD 4 and 5 Patients With Moderately Low Protein Diet (KETO-PROT-ACTION)Who this might be right forKidney Disease, Chronic University Hospital, Clermont-Ferrand 100
Large-scale testing (Phase 3)Study completedNCT01620489What this trial is testingEfficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal ImpairmentWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 279
Early research (Phase 1)Study completedNCT01316055What this trial is testingPharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal ImpairmentWho this might be right forRenal Insufficiency Acorda Therapeutics 42
Large-scale testing (Phase 3)Study completedNCT03281538What this trial is testingExtension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe PruritusWho this might be right forUremic Pruritus Cara Therapeutics, Inc. 288
Large-scale testing (Phase 3)Study completedNCT01968044What this trial is testingA Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment(GUARD Study)Who this might be right forType 2 DM Patients With Moderate or Severe Renal Impairment LG Life Sciences 132
Early research (Phase 1)Study completedNCT05940402What this trial is testingEvaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Compared With Participants With Normal Renal FunctionWho this might be right forRenal Impairment AbbVie 58
Post-approval studies (Phase 4)Study completedNCT03778567What this trial is testingRenoprotective Effects of Telbivudine in Chronic Hepatitis BWho this might be right forHepatitis B, ChronicChronic Kidney Diseases The University of Hong Kong 31
Early research (Phase 1)Study completedNCT01120314What this trial is testingPharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild, Moderate and Severe Renal ImpairmentWho this might be right forRenal Impairment Sanofi 48
Large-scale testing (Phase 3)Study completedNCT03636269What this trial is testingCR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe PruritusWho this might be right forUremic Pruritus Cara Therapeutics, Inc. 473
Testing effectiveness (Phase 2)Looking for participantsNCT05909059What this trial is testingCAR T-cell Therapy in Patients With Renal DysfunctionWho this might be right forNon-hodgkin Lymphoma,B CellMultiple MyelomaAcute Lymphoblastic Leukemia, Adult Northside Hospital, Inc. 20
Early research (Phase 1)WithdrawnNCT01832103What this trial is testingThe Pharmacokinetics of MK-7145 Following Single Dose Administration in Participants With Moderate Renal Insufficiency (MK-7145-018)Who this might be right forRenal Insufficiency Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT01309828What this trial is testingLong-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney DiseaseWho this might be right forSafety Takeda 153
Not applicableStudy completedNCT01399489What this trial is testingAerobic Training and Arterial Stiffness in Chronic Kidney Disease (CKD) PatientsWho this might be right forChronic Kidney DiseaseHypertensionDiabetes Springfield College 51